Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT: ILUVIEN in diabetic macular edema insufficiently responsive to available therapies
2016-001680-37Phase 4Active
- Sponsor
- Dr. José Maria Ruiz Moreno
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluocinolone in diabetic macular edema (DME), sponsored by Dr. José Maria Ruiz Moreno. Primary endpoint: Best corrected visual acuity at 2 years. Started Aug 2016; status: active.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2016-001680-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001680-37.